...
首页> 外文期刊>Journal of drug targeting >Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil.
【24h】

Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil.

机译:转铁蛋白偶联脂质体作为5-氟尿嘧啶脑靶向药物输送载体。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Diseases and disorders of the brain are extremely difficult to treat pharmacologically because most drugs are unable to pass across the blood--brain barriers. Complex multi-strand tight junctions between adjacent cerebral endothelial cells and between choroid plexus epithelial cells form a physical barrier and prevent the passage of water soluble drugs from the blood into the brain, whereas the inward passage of lipid soluble drugs is restricted by drug efflux pumps which act as a functional barrier. In the present work, a transferrin-coupled liposomal system for brain delivery of 5-florouracil has been investigated.5-florouracil and (99m)Tc-DTPA bearing non-coupled liposomes were prepared by cast film method, which were coupled with the transferrin by incubating these liposomes with transferrin in the presence of the 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride in saline phosphate buffer (pH 7.4). These liposomal systems were characterized for vesicle size, percent drug entrapment, andin vitro drug release. The size of the liposomes was increased on coupling with transferrin while percent drug entrapment reduced. The results of the in vitro release profile demonstrated that non-coupled liposomal formulation releases a comparatively higher percent (i.e. 74.8+/-3.21%) of drug than coupled liposomes. Results of in vivo study suggested a selective uptake of the transferrin-coupled liposomes from the brain capillary endothelial cells. In case of coupled liposomes, the level of radioactivity was 17-fold more as compared to the free radioactive agent and 13 times more with the non-coupled liposomes. Therefore, it could be concluded that using transferrin coupled liposomes the brain uptake of the drug could be enhanced.
机译:脑部疾病和病症很难用药理学来治疗,因为大多数药物都无法穿过血脑屏障。相邻的大脑内皮细胞之间和脉络丛上皮细胞之间复杂的多链紧密连接形成物理屏障,并阻止水溶性药物从血液进入大脑,而脂溶性药物的内向传播受到药物外排泵的限制充当功能障碍。在本工作中,研究了用于转运5-氟尿嘧啶的运铁蛋白偶联脂质体系统。通过流延膜法制备了5-氟尿嘧啶和(99m)Tc-DTPA的非偶联脂质体,并与转铁蛋白偶联。在盐酸盐磷酸盐缓冲液(pH 7.4)中,在1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐的存在下,将这些脂质体与转铁蛋白一起孵育。这些脂质体系统的特征是囊泡大小,药物截留百分数和体外药物释放。与运铁蛋白偶联后,脂质体的大小增加,而药物截留率降低。体外释放曲线的结果表明,与偶联脂质体相比,非偶联脂质体制剂释放的药物百分比更高(即74.8 +/- 3.21%)。体内研究结果表明,脑毛细血管内皮细胞选择性摄取了运铁蛋白偶联的脂质体。在偶联脂质体的情况下,与游离放射性试剂相比,放射性水平高出17倍,而在非偶联脂质体中,放射性水平高出13倍。因此,可以得出结论,使用转铁蛋白偶联脂质体可以增强药物的大脑摄取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号